Taken together, these results address some of the existing gaps in knowledge, establish a conceptual framework for the role of COX-1 in HGSOC tumors, and provide additional support for COX-1 as an attractive molecular target in ovarian cancer. This evidence concerns the gene PTGS1 and ovarian carcinoma.